Is the Treatment of Attention Deficit Hyperactivity Disorder a New Cause of Cataract?

• 作者: Mujdat Karabulut Seyhan Bahar Ozkan Sinem Karabulut Tolga Kocatürk
• 来源期刊: 眼科学期刊(英文)
• 学科: 医学
• 关键词: ATTENTION DEFICIT HYPERACTIVITY DISORDER METHYLPHENIDATE CATARACT
• 年，卷（期）: 2018,（1）
• 页码范围: 26-30
• 页数: 5页
• 分类号: R74

摘要

Attention deficit hyperactivity disorder (ADHD) is the most common behavioral disorder of childhood and it has 5% prevalence among children worldwide [1]. In the treatment of ADHD stimulant medications are recommended as the first choice of pharmacotherapy [2]. Methylphenidate-HCl is a sympathomimetic amine derivative pharmacological agent;and it is widely used in the treatment of ADHD. Although there are some articles showing that oral methylphenidate increases the risk of glaucoma [3], to the best of our knowledge, there is only one case report that indicates a possible relation of methylphenidate treatment and cataract formation [4].